This message was sent to ##Email##
Advertisement
|
|
|
|
|
|
Advertisement
|
|
|
SLAS
A quest for a personal best resulted in a shift in research focus for Eran Segal, Ph.D., who digs deep into the microbiome of the human gut for clues to optimizing health and preventing and fighting disease by building a better diet. "What is the best diet for humans? After reading years of research, I wanted to know why there was not a definitive answer," says Segal, a professor in the Department of Computer Science and Applied Mathematics at the Weizmann Institute of Science (Rehovot, Israel) and a keynote speaker for SLAS2019 (Feb 2-6, Washington, DC, USA). In a new article in SLAS Electronic Laboratory Neighborhood (SLAS ELN), Segal reveals that researchers were asking the wrong questions, "because it assumes that the best diet depends only on the food and not the person eating it."
READ MORE
Advertisement
SLAS
Need another boost of funding or technical support to get your research or innovation to the next level? SLAS invites research scientists who are looking for collaboration partners to submit abstracts for the SLAS Ignite Academic Collaboration Presentations to be held at the SLAS2019 International Conference and Exhibition. Tap into the experience, insights and capabilities of the well-connected SLAS community! If your abstract is chosen for presentation, you'll be assigned a 20-minute presentation slot in front of a diverse audience of engineers, researchers, scientists, business leaders, academicians and industry experts to help you advance your scientific research. Abstracts must be submitted by Oct. 31.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
SLAS
From objects as small as a mango to those as large as a semi-truck container; from complicated currency transactions in cyberspace to data as unique as personal identification documents, blockchain technology tracks the details of daily life with precision accuracy. Learn more about how it is poised to impact drug discovery collaborations at the SLAS Americas Sample Management Symposium, Managing Samples from Bench to Clinic (Nov. 13-14, Boston, MA, USA). Register now and join Keynote Tyler Mulvihill, co-founder at Viant, ConsenSys (New York), as he unlocks the mystery of blockchain and other exponential technologies.
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Groups that rely on Excel files to manage scientific data and communicate results run the risk of operating inefficiently, and their scientific innovation and new development candidates frequently suffer. With this free report , learn how viDA Therapeutics streamlined their processes and improved collaboration.
|
|
SLAS
SLAS is seeking to recruit an energetic professional with a specific focus on the management and effective execution of SLAS scientific journals — SLAS Discovery and SLAS Technology. Qualified candidates must work closely with two editors-in-chief, two editorial boards and members of the professional team to oversee all aspects of publishing for the peer-reviewed scientific journals. Responsibilities include planning, budgeting and operations, and developing, managing and meeting production and publishing schedules for the SLAS journals. The candidate must manage relationships with the journal publishing company, as well as provide support to authors and reviewers, while building relationships with volunteers and eliciting their ideas and support for current and future publishing endeavors.
READ MORE
|
Advertisement
|
|
|
Advertisement
|
|
|
SLAS
The answer is YES! Mark important abstract submission deadlines on your calendar for the SLAS2019 International Conference and Exhibition (Feb. 2-6, 2019, Washington, DC, USA). There is still time to gain recognition for your life sciences research by submitting abstracts for consideration to the following:
Take advantage of the Member-Only Registration Discount (deadline Wednesday, Oct. 31) to save $90 off the early-bird discount rate.
READ MORE
Advertisement
 |
|
Anton Paar’s Modular Sample Processor allows pipetting, sampling, dosing and weighing to be automated. Available as a benchtop unit or a complete solution integration. MORE
|
|
SLAS
SLAS Technology guest editors seek manuscript proposals (abstracts) for three new special issues:
(SLAS Technology is formerly known as the Journal of Laboratory Automation.)
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
SLAS
Today SLAS is in lovely Leiden (Netherlands) birthplace of Rembrandt, planting site of Holland's first tulip bulbs and home of the 2018 SLAS Advanced 3D Human Models and High-Content Analysis Conference (Oct. 17-19). Conference participants can expect the latest news in human tissue models and learn more about meaningful results in human disease models.
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
AMRI’s integrated drug discovery centers of excellence combine scientific expertise and leading-edge technology to accelerate innovation. Our complete suite of solutions includes comprehensive discovery biology, synthetic and medicinal chemistry, DMPK and bioanalytical services for successful hit-to-lead-to-candidate selection.
Contact us to put our Discovery expertise to work for you, contact: Customerservice@amriglobal.com.
|
|
SLAS
SLAS Discovery guest editors seek manuscript proposals (abstracts) for two upcoming special issues:
(SLAS Discovery is formerly known as the Journal of Biomolecular Screening.)
READ MORE
|
|
Journal of the American Chemical Society
Despite the frequent use of silver nanoparticles in consumer products and medical treatments, their reactivity and degradation in aqueous suspensions are still under debate. Here we elucidate this reactivity by an in situ opto- and spectro-electrochemical approach. Using dark-field microscopy coupled to a spectrophotometer and to an electrochemical cell, redox reactions of individual silver nanoparticles are studied in the presence of chloride.
READ MORE
Analytical Chemistry
The vast array of molecular isomerisms which form the complex molecular structure of carbohydrates is the foundation of their biological versatility but defies the analytical chemist. Hyphenations of mass spectrometry with orthogonal structural characterization, such as ion mobility or ion spectroscopy, have recently shown great promise for distinction between closely related molecular structures.
READ MORE
Phys.org
Designing synthetic proteins that can act as drugs for cancer or other diseases can be a tedious process: It generally involves creating a library of millions of proteins, then screening the library to find proteins that bind the correct target.
MIT biologists have now come up with a more refined approach in which they use computer modeling to predict how different protein sequences will interact with the target.
READ MORE
Science Daily
Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs.
Researchers say this new method of forming reactive intermediates called ketyl radicals offers scientists a way to use catalysts to convert simple molecules into complex structures in one chemical reaction. This is done in a less harsh, more sustainable and waste-free manner.
READ MORE
Chemical & Engineering News
As chiral molecules, nucleic acids can exist in enantiomeric forms. Although l-nucleic acids aren't found in nature, they could lead to development of new drugs that avoid degradation and immune response after they enter the human body. A team led by Jonathan Sczepanski of Texas A&M University reports the first example of a native RNA-binding protein that is capable of recognizing l-RNA.
READ MORE
Laboratory Equipment
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organization skills of a protein called Pax5.
The new study published in Nature Immunology shows how Pax5 helps to efficiently organize the genetic information required for our immune cells to maintain their form, function and help fight disease. The findings also suggest that a breakdown in this process of organization by Pax5 could increase the risk of diseases such as cancer.
READ MORE
Lab Manager
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents a collection of related but slightly different disorders, but until now it has not been possible to predict accurately which subtype of CD a patient is likely to develop.
READ MORE
Genetic Engineering & Biotechnology News
The results of studies by a team of scientists in the U.K. and Spain suggest that the commonly used antipsychotic drug Pimozide could offer a new treatment approach to the most hard to treat form of breast cancer, and potentially for lung cancer. The research found that Pimozide significantly reduced the size and number of human triple-negative breast cancer tumors in mice, and almost completely stopped the tumors from metastasizing to the lung.
READ MORE
Job Seekers: Post your résumé and sign up for new job alerts by keyword.
Employers: Search résumés, post an open position, internship or post-doc opportunity. SLAS Premier and Corporate Members get a discount on all new job postings.
Assistant/Associate Director of the Histocompatibility, Immunogenetics and Disease Profiling Lab
Stanford University
US – CA – Stanford
Chemical Biomedical Engineering – Academic Faculty Positions
The University of Sydney
Australia – New South Wales – Sydney
Neural Repair and/or Neurodegeneration Postdoctoral Fellowship
Strittmatter Lab, Yale University
US – CT – New Haven
SLAS Discovery / SLAS Technology Publishing Manager
SLAS
US – IL – Oak Brook
Search Jobs at SLAS Career Connections
| | THANK YOU 2018 SLAS CORPORATE MEMBERS |
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
